By proceeding, you agree to our Terms of Use and Privacy Policy.
The HFpEF Drug Discovery & Development Summit 2022 is the first industry-specific forum exclusively focused on showcasing the latest drug development and translational research in HFpEF and its relationship with metabolic syndromes and co-morbidities, whilst giving you the pivotal insights you need to kickstart the next generation of clinically def
The event is proud to unite large pharma, biotech and pioneering academicians to accelerate the therapy options for HFpEF, a common type of heart failure.
Find eye-opener research on disease heterogeneity, pathophysiological insights, analyse novel concepts beyond HFpEF drug re-purposing and much more!
Join 80+ experts at this forum with the likes of AstraZeneca, Eli Lilly, Bayer, Amgen, Novartis to find innovative solutions and optimize treatment options.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
AnaBios generates highly valuable, predictive human data in advance of clinical trials, ensuring the selection of the most effective and safest drugs, thereby reducing the time and expense related to clinical trial failures.
Driven by Science. Dedicated to Heart. Combining Deep Medical Expertise and Exceptional Client Focus.
Nordic Bioscience is the leading expert in extracellular matrix (ECM) research with 25+ years of experience in biomarker development, pre-clinical and clinical research.
OM1 is a leading health outcomes and registries company focused on the measurement, comparison, and prediction of treatment outcomes.
Physiogenex is a leading preclinical contract research organization (CRO) specializing in metabolic disorders such as diabetes, obesity, liver diseases, dyslipidemia, atherosclerosis and cardiovascular complications.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.